Clinical

SBRT for NSCLC: Comprehensive analysis of outcomes and recurrence from a single-center experience has been accepted for Oncology Letters!

Our paper “Stereotactic body radiotherapy for early-stage non-small cell lung cancer: Comprehensive analysis of outcomes and recurrence from a single-center experience” has been accepted by BMC cancer (IF=2.5).

Apr 1, 2025

Dummy run study of SABR for recurrence ovarian cancer (SABR-ROC) has been accepted for BMC cancer!

Congratulation! Our paper “Radiotherapy Quality Assurance Program of Ongoing Clinical Trial Using Stereotactic Ablative Radiation Therapy for Recurrent Ovarian Cancer (SABR-ROC): A Dummy Run Study of a Prospective, Randomized, Multicenter Phase III Trial (KGOG 3064/KROG 2204)” has been accepted by BMC cancer (IF=3.

Mar 10, 2025